Salivary Biomarkers in Erosive Oral Lichen Planus
Author Information
Author(s): Noha A. Ghallab, Naglaa El-Wakeel, Olfat G. Shaker
Primary Institution: Cairo University
Hypothesis
Can salivary levels of IFN-γ, TNF-α, and sTNFR-2 be used as prognostic markers in erosive oral lichen planus patients?
Conclusion
Salivary levels of IFN-γ, TNF-α, and sTNFR-2 are significantly higher in erosive oral lichen planus patients and decrease after treatment with prednisone.
Supporting Evidence
- Salivary levels of IFN-γ, TNF-α, and sTNFR-2 were significantly higher in erosive oral lichen planus patients compared to controls.
- After treatment with prednisone, salivary levels of these biomarkers decreased significantly.
- The study suggests the potential use of these biomarkers for diagnosis and monitoring of erosive oral lichen planus.
Takeaway
Doctors can check saliva to see if people with a mouth condition called erosive oral lichen planus have certain markers that change when they get treatment.
Methodology
The study involved 20 erosive oral lichen planus patients and 20 healthy controls, measuring salivary levels of biomarkers using ELISA before and after treatment with prednisone.
Limitations
The sample size was relatively small.
Participant Demographics
20 erosive oral lichen planus patients (18 female, 2 male; ages 40-55) and 20 healthy controls (17 female, 3 male; ages 41-56).
Statistical Information
P-Value
p ≤ .0001
Statistical Significance
p ≤ .01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website